New-onset chronic inflammatory demyelinating polyradiculoneuropathy after COVID-19 infection: a case report

• Published in: Annals of medicine and surgery (2012) Vol. 85; no. 10; pp. 5031 - 5034
• Main Authors: Abedi Samakoush, Mohammad, Davoodi, Lotfollah, Khademian, Mojtaba, Kargar-Soleimanabad, Saeed, Abedini, Mohammad-Ali
• Format: Report
• Language: English
• Published: 01-10-2023
• ISSN: 2049-0801; 2049-0801
• DOI: 10.1097/MS9.0000000000000352

Introduction and importanceSARS-CoV-2 infection, besides respiratory symptoms, as cardinal manifestation, may present with neurological involvement. Immune-mediated polyradiculoneuropathy is one of the important neurological complications manifested by COVID-19 mainly includes Guillain-Barré syndrome (GBS), treatment-related fluctuation of GBS, and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Also, there are several reports of COVID-19 vaccine-related GBS and CIDP. According to possible severe manifestations of neuropathies like respiratory failure, considering these complications for early diagnosis and treatment is very important. Case presentationThe authors presented a 67-year-old woman with severe weakness in upper and lower extremities, the patient was diagnosed as case with CIDP initiated after COVID-19 virus infection and/or vaccination that experienced one relapse in 11 months. In both episodes, treatment with intravenous immunoglobulin started and the patient respond. Clinical discussionTo the best of our knowledge, this is one of the first reported cases with a typical chronic course of CIDP associated with COVID-19 virus infection and/or vaccination. ConclusionConsidering this complication and differentiation between GBS and CIDP, and then initiating maintenance therapy can prevent long-term disability.